Affinity Asset Advisors, LLC: holdings and changes
Number 31 of the top 100 funds by copy return. Affinity Asset Advisors, LLC reported 106 US stocks worth $1.7B for the quarter ending 2026-09-30 and changed 25 new, 23 added, 24 trimmed and 20 sold since 2026-06-30.
Copy return, 4 quarters+55.5%
US 500, same time+14.5%
Size$1.7B
Stocks106
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| ROIV Roivant Sciences LTD | TRIM -15% | 6.80% | $117M | 3,200,000 |
| AEGLEA BIOTHER Aeglea Biotherapeutics INC | 6.61% | $114M | 1,279,134 | |
| ERAS Erasca INC Com | ADD +6% | 4.76% | $82M | 5,590,600 |
| TRAX First Tracks Biotherapeutics | 4.28% | $74M | 2,080,000 | |
| XENE Xenon Pharmaceuticals INC | ADD +19% | 4.11% | $71M | 1,900,374 |
| INSM Insmed INC. | TRIM -13% | 3.74% | $64M | 564,251 |
| ALKS Alkermes PLC | ADD +39% | 3.68% | $63M | 1,565,000 |
| ORKA Oruka Therapeutics INC | 2.90% | $50M | 600,000 | |
| AVTX Avalo Therapeutics INC | ADD +12% | 2.89% | $50M | 3,244,861 |
| CYTK Cytokinetics INC. | ADD +36% | 2.87% | $49M | 750,000 |
| RVMD Revolution Medicines INC | TRIM -10% | 2.68% | $46M | 225,000 |
| PRAX Praxis Precision Medicines I | TRIM -16% | 2.62% | $45M | 155,000 |
| BLTE Belite Bio INC | ADD +47% | 2.39% | $41M | 242,088 |
| CLDX Celldex Therapeutics INC | ADD +66% | 2.18% | $38M | 1,160,499 |
| ABVX Abivax Sa-Adr | 1.90% | $33M | 330,000 | |
| DNTH Dianthus Therapeutics INC | TRIM -12% | 1.79% | $31M | 350,000 |
| ODTX Odyssey Therapeutics, INC. | ADD +64% | 1.63% | $28M | 1,260,000 |
| ARWR Arrowhead Pharmaceuticals, INC. | ADD +183% | 1.62% | $28M | 425,000 |
| TRVI Trevi Therapeutics | 1.50% | $26M | 1,800,172 | |
| OVID Ovid Therapeutics INC | 1.47% | $25M | 10,144,562 | |
| SGMT Sagimet Biosciences INC. | 1.45% | $25M | 2,527,384 | |
| LXEO Lexeo Therapeutics INC | ADD +25% | 1.42% | $24M | 7,245,611 |
| PTGX Protagonist Therapeutics INC | 1.41% | $24M | 172,125 | |
| NRIX Nurix Therapeutics INC | 1.33% | $23M | 967,620 | |
| VOGX Vogenx INC | BUY | 1.21% | $21M | 915,000 |
| MLYS Mineralys Therapeutics INC | 1.09% | $19M | 750,000 | |
| TYRA Tyra Biosciences INC | ADD +325% | 1.08% | $19M | 850,000 |
| STRO Sutro Biopharma INC | 1.08% | $19M | 1,152,487 | |
| TVTX Travere Therapeutics INC | 1.03% | $18M | 300,000 | |
| ANRO Alto Neuroscience INC | TRIM -24% | 0.95% | $16M | 643,343 |
| ARVN Arvinas INC | BUY | 0.92% | $16M | 2,050,000 |
| EPRX Eupraxia Pharmaceuticals INC | ADD +4% | 0.91% | $16M | 1,716,320 |
| RLAY Relay Therapeutics INC | TRIM -19% | 0.89% | $15M | 850,000 |
| MDGL Madrigal Pharmaceuticals INC | TRIM -25% | 0.88% | $15M | 30,000 |
| CULLINAN ONCOL Cullinan Oncology INC | 0.78% | $13M | 875,760 | |
| SVRA Savara INC | 0.75% | $13M | 2,512,153 | |
| COAG Hemab Therapeutics Hldgs INC | ADD +204% | 0.75% | $13M | 420,000 |
| ELIEM THERAPEU Eliem Therapeutics INC | 0.65% | $11M | 972,000 | |
| IBRX Immunitybio INC | BUY | 0.65% | $11M | 1,180,000 |
| BEAM Beam Therapeutics INC | BUY | 0.64% | $11M | 450,000 |
| CATX Perspective Therapeutics INC | TRIM -5% | 0.64% | $11M | 3,988,744 |
| JBIO Jade Biosciences INC | TRIM -10% | 0.62% | $11M | 760,350 |
| PRLD Prelude Therapeutics INC | BUY | 0.59% | $10M | 2,600,000 |
| CRSP Crispr Therapeutics Ag | ADD +75% | 0.56% | $10M | 175,000 |
| MANE Veradermics INC | TRIM -21% | 0.56% | $10M | 79,400 |
| ESTA Establishment Labs Hldgs INC | 0.56% | $10M | 149,779 | |
| AMLX Amylyx Pharmaceuticals INC Com | ADD +203% | 0.51% | $9M | 300,000 |
| KRSA Korsana Biosciences INC | BUY | 0.49% | $8M | 263,106 |
| PROQR THRAPEUT Proqr Thrapeutics N V | TRIM -10% | 0.48% | $8M | 4,970,074 |
| VERA Vera Therapeutics INC | 0.47% | $8M | 250,000 | |
| DMRA Damora Therapeutics INC Com Shs | BUY | 0.46% | $8M | 375,000 |
| RACC Research Alliance Corp III | ADD +99% | 0.46% | $8M | 735,538 |
| SLGL Sol Gel Technologies | ADD +24% | 0.45% | $8M | 105,000 |
| IDYA Ideaya Biosciences INC | TRIM -50% | 0.45% | $8M | 200,000 |
| AVR Anteris Technologies Global | 0.41% | $7M | 912,397 | |
| AKTS Aktis Oncology INC | BUY | 0.40% | $7M | 350,000 |
| ELVN Enliven Therapeutics INC | TRIM -70% | 0.39% | $7M | 148,000 |
| NAMS Newamsterdam Pharma Company | 0.39% | $7M | 275,000 | |
| HLXC Helix Acquisition Corp III | TRIM -50% | 0.39% | $7M | 625,000 |
| XFOR X4 Pharmaceuticals INC Com New | ADD +1322% | 0.35% | $6M | 2,062,500 |
| KRRO Korro Bio INC | TRIM -25% | 0.31% | $5M | 531,904 |
| VRDN Viridian Therapeutics INC | 0.30% | $5M | 250,000 | |
| SLN Silence Therapeutics PLC | BUY | 0.29% | $5M | 450,000 |
| IBIO Ibio INC | ADD +3% | 0.28% | $5M | 4,130,427 |
| TSHA Taysha Gene Therapies INC Com Shs | TRIM -43% | 0.28% | $5M | 1,000,000 |
| SABS Sab Biotherapeut | 0.28% | $5M | 1,525,000 | |
| OCUPHIRE PHARM Ocuphire Pharma INC | BUY | 0.25% | $4M | 900,000 |
| SENSEI BIOTHER Sensei Biotherapeutics INC | 0.25% | $4M | 144,404 | |
| EQ Equillium INC | TRIM -36% | 0.25% | $4M | 2,613,954 |
| NTLA Intellia Therapeutics INC | BUY | 0.25% | $4M | 350,000 |
| LTGO Latigo Biotherapeutics INC | BUY | 0.24% | $4M | 250,000 |
| RZLT Rezolute INC | 0.24% | $4M | 1,000,000 | |
| ARK ETF TR Ark ETF Tr | BUY | 0.24% | $4M | 74,900 |
| DTIL Precision Biosciences INC | 0.24% | $4M | 646,576 | |
| AMAN Amanat Acquisition Corp | 0.23% | $4M | 375,000 | |
| CMPS Compass Pathways PLC | 0.22% | $4M | 301,183 | |
| RNAQ Rainier Acquisition Corp | BUY | 0.22% | $4M | 364,957 |
| MGNX Macrogenics INC | TRIM -22% | 0.21% | $4M | 953,979 |
| RACD Research Alliance Corp Iv | BUY | 0.21% | $4M | 300,000 |
| IMVT Immunovant INC | 0.20% | $3M | 100,000 | |
| APOGEE THERA I Apogee Thera INC | SELL | 0% | was $131M | 0 |
| NUVALENT INC Nuvalent INC | SELL | 0% | was $34M | 0 |
| FORTE BIOSCIEN Forte Bioscience INC | SELL | 0% | was $24M | 0 |
| COGT Cogent Biosciences INC | SELL | 0% | was $17M | 0 |
| TEVA Teva Pharm Inds LTD Adrf Spons | SELL | 0% | was $13M | 0 |
| GALECTO INC Galecto INC | SELL | 0% | was $11M | 0 |
| QURE Uniqure Nv | SELL | 0% | was $8M | 0 |
| ASND Ascendis Pharma A/S | SELL | 0% | was $8M | 0 |
| ASMB Assembly Biosciences INC | SELL | 0% | was $5M | 0 |
| BHVN Biohaven LTD | SELL | 0% | was $4M | 0 |
| KPTIQ Karyopharm Therapeutics INC | SELL | 0% | was $3M | 0 |
| ALEC Alector INC Com | SELL | 0% | was $3M | 0 |
| SGP Spyglass Pharma INC | SELL | 0% | was $3M | 0 |
| CRINETICS PHAR Crinetics Pharmaceuticals In | SELL | 0% | was $3M | 0 |
| SPRB Spruce Biosciences INC | SELL | 0% | was $2M | 0 |
| OKUR Onkure Therapeutics INC | SELL | 0% | was $1M | 0 |
| ENGN Engene Therapeut | SELL | 0% | was $1M | 0 |
| BOLD Boundless Bio INC | SELL | 0% | was $600k | 0 |
| OBIO Orchestra Biomed Hldgs INC | SELL | 0% | was $100k | 0 |
| WTS ROCKET PHA Wts Rocket Pharmaceuticals INC | SELL | 0% | was $0k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2024-03-31 → 2024-06-30 | -12.5% | +4.0% |
| 2024-06-30 → 2024-09-30 | +13.7% | +5.4% |
| 2024-09-30 → 2024-12-31 | -7.8% | +2.1% |
| 2024-12-31 → 2025-03-31 | -18.2% | -4.6% |
| 2025-03-31 → 2025-06-30 | +11.1% | +10.5% |
| 2025-06-30 → 2025-09-30 | +34.1% | +7.8% |
| 2025-09-30 → 2025-12-31 | +29.8% | +2.4% |
| 2025-12-31 → 2026-03-31 | +10.5% | -4.6% |
| 2026-03-31 → 2026-06-30 | +22.6% | +14.8% |
| 2026-06-30 → 2026-09-30 | -11.5% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP